1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Five-Year Outcome of Cholinergic Treatment of Alzheimer's Disease: Early Response Predicts Prolonged Time until Nursing Home Placement, but Does Not Alter Life Expectancy.
(
- Contribution to journal › Article
- 2001
-
Mark
Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients
(
- Contribution to journal › Article
- 1997
-
Mark
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
(
- Contribution to journal › Article
-
Mark
Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia
(
- Contribution to journal › Article
- 1996
-
Mark
Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article
- 1995
-
Mark
Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease
(
- Contribution to journal › Article
- 1994
-
Mark
Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Neuropsychological tests as discriminators between dementia of Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article
- 1993
-
Mark
Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration
(
- Contribution to journal › Article
-
Mark
Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG
(
- Contribution to journal › Article